730010Dermal ConstructClosedLegacy RDA Grant for R&DInnovate UKSCD Ltd has patented a population of stem cells from adult hair follicles which promote wound healing and skin regeneration. SCD Ltd, in collaboration with Avecia, has developed processes to manufacture these cells.This grant will cover phase 1 of product development during which we will • Develop a tissue engineered human skin construct • Demonstrate the capability for cell production • Demonstrate the enhanced wound healing capacity of the cells The aim of Phase 1 is to combine the patented hair follicle dermal cells and the patented bioprocess with woundhealing and matrix expertise from Durham University. The major deliverable is a skin construct upon which a number of SCD products are based. Initially this technology will be incorporated into products for in vitro cosmetic and drug testing to be launched in 2011. This aspect of phase 1 is funded by a grant from TSB.